Digest Network Come funziona
Network
/
Società
Tu
Non verificato

Turn Therapeutics

Di cosa scriviamo

FarmaceuticaIndustriaSaluteSanitàScienza

8 comunicati stampa

Guarda tutti i comunicati
29/09/2025
Biotecnologia
Farmaceutica
Salute
Sanità
Titoli e azioni
Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
15/09/2025
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Turn Therapeutics to Host Open Investor Session in Connection with Expected Public Listing on Nasdaq
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
06/08/2025
Scienza
Farmaceutica
Salute
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Industria
Turn Therapeutics Intranasal Vaccine Candidate Demonstrates Extended Stability
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
14/07/2025
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Industria
Turn Therapeutics Begins Clinical Trial of First Topical IL-36/IL-31 Inhibitor for Eczema
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
02/05/2025
Industria
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Sanità
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
02/04/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Turn Therapeutics Launches Final Crowdfund Round Ahead of Eczema Trial Enrollment, Engages Clear Street to Explore Public Markets
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
05/02/2025
Sanità
Scienza
Farmaceutica
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Salute
Industria
Turn Therapeutics Achieves 24-Hour Stability for Live Vaccine in Intranasal Oil Suspension at Room Temperature, Marking Major Milestone Toward Improving Vaccine Access
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0
12/12/2024
Sanità
Finanza
Salute
Associazioni/Professionisti
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
Fonte
Turn Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0